Loading...
  • vascular
  • The medical charts of diabetic men with vascular ED from a single-sex clinic were reviewed, as well as the medical charts of body mass index (BMI)- and age-matched diabetic men without ED going through routine check-ups. (biomedsearch.com)
  • Osteoprotegerin and biomarkers of vascular inflammation in type 2 diabetes. (lenus.ie)
  • OPG inhibits vascular calcification in vitro and high serum levels have been demonstrated in type 2 diabetes, but serum RANKL and TRAIL and their potential correlation with well-established biomarkers of subclinical vascular inflammation such as high-sensitivity C-reactive protein (hsCRP) and interleukin-6 (IL-6) have not been described. (lenus.ie)
  • arterial
  • The aim of the present thesis was to assess the occurrence of early lower extremity arterial disease (LEAD) in patients with diabetes and to assess novel potential risk markers for development or worsening of LEAD in the same patients. (diva-portal.org)
  • Are predictors of coronary heart disease and lower-extremity arterial disease in type 1 diabetes the same? (naver.com)
  • UKPDS
  • A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68). (ox.ac.uk)
  • chronic
  • The primary objective of this study is to compare the rate of healing as well as percent of wounds healed in Type II diabetic patients with chronic foot ulcerations receiving sitagliptin versus placebo. (clinicaltrials.gov)
  • blood pressure
  • The measurement of ankle-to- brachial blood pressure index (ABI) to screen for asymptomatic LEAD in diabetic subjects is unreliable since a large proportion of patients have stiff ankle arteries (mediasclerosis) and thus may display a too high ABI. (diva-portal.org)
  • Thus, it was found that toe blood pressure measurements, alone or in combination with ankle blood pressure measurements, increase the sensitivity for finding early asymptomatic LEAD in diabetic subjects. (diva-portal.org)
  • outcomes
  • The model allows simulation of a range of long-term outcomes, which should assist in informing future economic evaluations of interventions in type 2 diabetes. (ox.ac.uk)
  • Glycemic
  • Age, hypertension and glycemic control are well known risk factors and, in addition, high tissue plasminogen activator (tPA) activity turned out to be a novel early marker for asymptomatic LEAD in diabetic subjects, particularly in patients with type 2 diabetes. (diva-portal.org)
  • studies
  • The early pharmacodynamic and pharmacokinetic effects of mixing lispro with glargine insulin: results of glucose clamp studies in youth with type 1 diabetes. (yale.edu)
  • risk
  • On the other hand, an abnormal heart rate profile during exercise stress testing predicts poor cardiovascular prognosis in high-risk patients, such as diabetic men, even in the absence of CHD. (biomedsearch.com)
  • AIM: In order to study if ED predicts poor cardiovascular prognosis in high-risk patients, we examined the association between ED and heart rate profile during exercise stress testing in diabetic men with no CHD. (biomedsearch.com)
  • Central obesity is increasingly recognized as a risk factor for atherosclerosis and type 2 diabetes mellitus. (naver.com)
  • results
  • The Sexual Health Inventory for Men (SHIM) questionnaire was used to characterize ED. RESULTS: Included were 18 diabetic men with ED (SHIM questionnaire scores 5-21) and 18 diabetic men without ED (SHIM questionnaire scores 22-25), 40 years of age or older. (biomedsearch.com)
  • medical
  • We analyzed the medical records of 884 type 2 DM patients who were taking different antiplatelet agents for more than 2 years. (biomedsearch.com)
  • Index
  • Sixty-two patients with well-controlled type 2 diabetes and an age, gender and body mass index-matched group of 58 healthy individuals were recruited. (lenus.ie)